Drug Policy Impact: The U.S. Orphan Drug Act (1983) helped flip rare-disease treatment from a neglected niche into more than half of FDA’s new drug approvals. Medical Tech Growth: Market forecasts point to rapid expansion in 3D-printed medical devices and wearable medical devices, driven by point-of-care manufacturing and remote monitoring reimbursement. AI in Pharma: Bristol Myers Squibb is adding a second Nvidia DGX SuperPOD to speed AI-assisted target identification from weeks to days, alongside Nvidia’s BioNeMo tools. Biotech & Trials: Oncolytics won FDA Fast Track for pelareorep in advanced anal cancer, while CurePSP announced its biggest grant cycle for PSP/CBD research. Healthcare Data & Security: Navy Medicine’s IT excellence award highlights major reductions in network outages, and cyber leaders push for extending Zero Trust to code itself. Standards for AI: Experts at WAIC argue AI standards must split into stable principles and “living” technical metrics. Energy & Climate Tech: Queen’s researchers unveiled a 3D-printed battery aimed at grid-scale storage, and India reiterated no move beyond E20 ethanol blending without further studies. Tech Infrastructure: DGS and Revells plan to pair spectrum intelligence with private 5G for industrial sites, while AMD and Microsoft expand Azure deployments for frontier model inference. Environment & Public Health: A Louisiana environmental justice investigation alleges toxic-air monitoring gaps and limits on how residents can use collected data. Construction Outlook: Canada’s BuildForce forecasts rising construction demand through 2035 in Alberta, Saskatchewan, and Manitoba, led by non-residential and renovation activity. Science Breakthrough: Researchers detected hidden early skin collagen damage before it shows up on conventional scans.